Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q16637 (
SMA
)
8,107
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
transcription factor-like nuclear regulator
(
TFNR
) is a novel human gene that maps on 5q13, distal to the duplicated region that includes
SMN1
, the spinal muscular atrophy (SMA) determining gene. The location of
TFNR
allowed us to design an evolutionary model of the SMA region. The 9.5-kb
TFNR
transcript is highly expressed in cerebellum and weakly in all other tissues tested.
TFNR
encodes a protein of 2254 amino acids (aa) and contains nine repeats of a novel 55-aa motif, of yet unknown function. The coding region is organized in 32 exons. Alternative splicing of exon 15 results in a truncated protein of 796 aa.
TFNR
comprises a series of polypeptides that range from 55 to 250 kDa. Immunocytological studies showed that the
TFNR
protein is present exclusively in the nucleus, where it is concentrated in several nuclear structures. Amino acids 155-474 show significant homology to
TFC5
, a subunit of the yeast transcription factor TFIIIB, suggesting that
TFNR
is a putative transcription factor. Based on its proximity to
SMN1
and its expression pattern,
TFNR
may be a candidate gene for atypical forms of SMA with cerebral atrophy and axonal neuropathy that have been shown to carry large deletions in the SMA region.
...
PMID:The transcription factor-like nuclear regulator (TFNR) contains a novel 55-amino-acid motif repeated nine times and maps closely to SMN1. 1116 82